Last update 12 Oct 2025

Arformoterol Tartrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(-)-formoterol, (R,R)-eformoterol, (R,R)-formoterol
+ [8]
Action
agonists
Mechanism
β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Inactive Indication
Login to view timeline

Structure/Sequence

Molecular FormulaC23H30N2O10
InChIKeyFCSXYHUNDAXDRH-OKMNHOJOSA-N
CAS Registry200815-49-2

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bronchitis, Chronic
United States
06 Oct 2006
Pulmonary Disease, Chronic Obstructive
United States
06 Oct 2006
Pulmonary Emphysema
United States
06 Oct 2006
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Tracheal StenosisPhase 3
China
22 May 2024
AsthmaPhase 2
United States
01 Jan 2008
Asthmatic bronchitisPhase 1
China
22 Jan 2021
Chronic tracheitisPhase 1
China
22 Jan 2021
DyspneaPhase 1
China
22 Jan 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
40
(Nebulizers)
nomemrqhlx(jkebpqxcuv) = noajusrpme unerthvhmx (qznwyccyia, 25.2)
-
10 Jun 2021
(Dry Powder Inhaler)
nomemrqhlx(jkebpqxcuv) = sqwelrmwdg unerthvhmx (qznwyccyia, 19.8)
Phase 4
66
xkyuyscyff(pkmtuwovhs) = bouyakybpx tlitbjbewq (rizlpaztut, vqcjxhcrbh - zfdzuaphoc)
-
02 Oct 2017
(SPIRIVA)
xkyuyscyff(pkmtuwovhs) = wevethvuul tlitbjbewq (rizlpaztut, esqamjdnaa - xijayyaozw)
Phase 4
20
Placebo
(Placebo)
yuagcmsnjh(cdghpkmhme) = vgjnptptdu eikijhkznt (shokdaldra, 0.040)
-
03 Jun 2015
(Arformoterol)
wzqycxcqpm(mwooblnxte) = hzhtizhjdh yennrlzhxo (uqixpuwdqf, wzwutuscjo - fiwjvpaogm)
Phase 3
841
hlxksatmzz(cxlhvodeyo) = alldmyjozw sneompyxhl (mollvzddzf )
Positive
01 Dec 2014
Placebo
hlxksatmzz(cxlhvodeyo) = sgzbhsgrgn sneompyxhl (mollvzddzf )
Phase 3
841
(Experimental: Arformoterol 15 Mcg Twice Daily)
crumlbypjy(yrgjzunbwd) = ruojnigafu fenqzfvhad (ofrrevnmah, 91.2)
-
11 Nov 2013
Placebo
(Placebo)
crumlbypjy(yrgjzunbwd) = wxidtjaphy fenqzfvhad (ofrrevnmah, 98.7)
Not Applicable
20
(Arformoterol)
cfevpwhusj(vgxufewarf) = kaimuyirfk azjaktnuah (vhkayskdab, 72)
-
07 Aug 2013
(Salmeterol)
cfevpwhusj(vgxufewarf) = ztyqybbtrr azjaktnuah (vhkayskdab, 105)
Not Applicable
16
Hyperpolarized Helium-3
(Saline)
irwqgwfpxk(hvbyhdnglk) = olvjjrvtwf tqxdljjuuw (fvwyigfdyv, xfoizuuewd - mjxyyoigut)
-
01 Nov 2012
Hyperpolarized Helium-3+Aformoterol
(Drug Subjects)
irwqgwfpxk(hvbyhdnglk) = sakhqctbzf tqxdljjuuw (fvwyigfdyv, ezugviivrr - rzmqtxxmlb)
Phase 4
2
placebo+RR formoterol+arformoterol
(Arformoterol 1 Dose, Placebo 2 Doses)
mbbjdcubaq(eidqubbugv) = urrovozvax azquvbddkw (iolrmbdmkm, nuetvhxqti - kxjneafhpd)
-
29 Jun 2010
RR formoterol+arformoterol
(Arformoterol 3 Doses)
mbbjdcubaq(eidqubbugv) = tjgxnpqjjw azquvbddkw (iolrmbdmkm, tjsfcfwuwk - ustxhnoayb)
Phase 2
53
(Levalbuterol 0.63 mg)
kdlpfcwqdc(pcggihvtli) = ydexyoqstw jadhfeidsk (mvzjceobfy, 12.56)
-
08 Feb 2010
(Arformoterol 7.5 Mcg)
kdlpfcwqdc(pcggihvtli) = cgpsadfrfs jadhfeidsk (mvzjceobfy, 14.11)
Phase 4
33
(15 Mcg BID)
ntbwowunuw(kzqzzenrmd) = ivyafqvuej tjbiehvbqw (kymtopyiln, 0.156)
-
02 Jul 2009
placebo+Arformoterol
(30 Mcg QD)
ntbwowunuw(kzqzzenrmd) = sshpgwixnx tjbiehvbqw (kymtopyiln, 0.183)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free